Omeros Corporation Share Price

Omeros Corporation Share Price

NASDAQ: OMER | Small Cap
$18.94
+$1.07 (5.99%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Omeros Corporation Stock Performance

Open
$17.93
Prev. Close
$17.87
Circuit Range
N/A
Day Range
$17.70 - $19.28
Year Range
$6.24 - $21.23
Volume
2,41,355
Average Traded
$18.87

Omeros Corporation Share Price Today

As of 30 October 2026, Omeros Corporation's share price is $18.94. The stock opened at $17.93, compared to its previous close of $17.87. During today's trading session, Omeros Corporation's share price traded between $17.70 and $19.28, with an average price of $18.49. Over the past 52 weeks, the stock has recorded a high of $21.23 and a low of $6.24. In terms of performance, Omeros Corporation's share price has risen by 29.90% over the last six months and is up 158.74% on a year-on-year basis.

Omeros Corporation Share Price Chart

Line chart of the Omeros Corporation price trend over the selected period. The price rose overall, ranging from 17.69 to 19.25, ending at 18.93.
$17.70$19.28
L
Show Current Price
H

Omeros Corporation Stock Fundamentals & Key Indicators

Market Cap
$1.20B
PE Ratio (TTM)
10.37
Dividend Yield
0.00%
EPS (TTM)
$1.72
Revenue (TTM)
$0.00
Return On Equity (TTM)
-243.09%
Profit Margin
N/A
Debt to Equity
-1.43
Quarterly Earnings Growth YoY
142.79%

Omeros Corporation Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$9.89$28.53
Net Profit-$30.92$86.45$56.06$13.23
Net Profit MarginN/AN/A566.84%46.37%
Income ChangeN/A379.59%-35.15%-76.40%

Omeros Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit$47.42-$117.81-$156.82-$3.35
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-348.44%-33.11%97.86%

About Omeros Corporation

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.

Omeros Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$18.86
$18.95
-0.63%
Sep 2026
$18.67
$19.07
-0.91%
Aug 2026
$12.29
$19.25
+62.31%
Jul 2026
$9.56
$11.86
+24.58%
Jun 2026
$10.90
$9.52
-13.73%
May 2026
$14.69
$11.04
-24.31%
Apr 2026
$11.39
$14.58
+37.94%
Mar 2026
$11.99
$10.57
-12.32%
Feb 2026
$11.56
$12.05
+2.95%
Jan 2026
$17.26
$11.71
-31.84%
Dec 2025
$9.82
$17.18
+77.66%
Nov 2025
$7.29
$9.67
+32.10%

OMER Share Price FAQs